Oral Presentation【See before session】
PHASE II CLINICAL TRIAL OF THE ADDITION OF DENDRITIC CELL VACCINES TO NEOADJUVANT CT IN HER2 –ve BC PATIENTS
Marta Santisteban1(1. Clínica Universidad de Navarra)
This video stream has finished.
Outcomes of CDK46 inhibitors in patients with HR+HER2- metastatic breast cancer : A retrospective single institution study
Akane Higami1, Masahiro Takada1, Jaxi He1, Makoto Fujino1, Yuki Nakkmura1, Rie Nakagawa1, Yukiko Inagaki1, Nobuko Kawaguchi1, Kosuke Kawaguchi1, Masahiro Kawashima1, Yukiko Mori1, Eiji Suzuki1, Masakazu Toi1 (1. Kyoto University Hospital)
This video stream has finished.
Updated result of cisplatin-based preoperative chemotherapy for triple-negative breast cancer patients who did not achieve pCR
Ayane Yamaguchi1, Kosuke Kawaguchi1, Hiroshi Ishiguro2, Tatsuki R Kataoka3, Akiyoshi Nakakura7, Masae Torii4, Yukiko Mori5, Nobuko Kawaguchi-Sakita6, Masahiro Kawashima1, Masahiro Takada1, Eiji Suzuki1, Satoshi Morita7, Masakazu Toi1 (1. Breast Surgery, Kyoto University Graduate School of Medicine, 2. Breast Oncology Service, Saitama Medical University International Medical Center, 3. Molecular Diagnostic Pathology, Iwate Medical University, 4. Breast Surgery, Japanese Red Cross Wakayama Medical Center, 5. Therapeutic Oncology, Kyoto University Hospital, 6. Clinical Oncology, Kyoto University Hospital, 7. Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine)
This video stream has finished.
【Jia Wang】
JIA WANG1, PAN QIN2, YUTING ZHANG3, DIANLONG ZHANG4, FENG JIN5 (1. 2nd Hospital of Dalian Medical University, 2. Dalian University of Technology, 3. Dalian Medical University, 4. Zhongshan Hospital of Dalian University, 5. 1st Affiliated Hospital of China Medical University)
This video stream has finished.
【Takayuki Kadoya】
Takayuki Kadoya1 (1. Department of Surgical Oncology, Hiroshima University)
This video stream has finished.